<DOC>
	<DOCNO>NCT01732406</DOCNO>
	<brief_summary>The investigator hypothesize treatment acromegaly associate improvement quality life compare active acromegaly . At time , also study effect different acromegaly treatment quality life .</brief_summary>
	<brief_title>Acromegaly Treatment Quality Life Study</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Age 1890 Active acromegaly receive pegvisomant monotherapy receive somatostatin analog monotherapy Untreated thyroid adrenal insufficiency . Subjects replacement therapy must stable least 3 month prior entry study Initiation discontinuation testosterone estrogen within 3 month entry Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>